Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Jan 27th, 11:54 PM EST
When elegance, punctuality and professionalism are of the utmost importance, Paris Orly chauffeur service by Noble Transfer offers a travel experience that goes beyond. Whether you are flying in for business, leisure or a special event, you deserve a flying service that combines luxury with reliability -- the kind of refinement that is sure to make every moment in Paris unforgettable.
Via AB Newswire · January 27, 2026
The US Formally Exits the World Health Organization
The United States has formally communicated its immediate withdrawal from the World Health Organization (WHO), denying the global body one of its largest donors. The withdrawal follows the signing of an executive order to this effect during the first months of Trump’s current administration.
Via Investor Brand Network · January 27, 2026
Las Vegas-based company, All European Auto Repair, is pleased to announce that the knowledgeable and experienced mechanics are ASE-certified and can handle any vehicle problem that customers might be faced with, but the company specializes in the repair of luxury vehicles such as Mercedes-Benz, Rolls-Royce, Jaguar, BMW, Bentley, Audi, and Range Rover. The services range from oil changes and engine diagnostics to belt and hose repairs, air conditioning, brake repairs, tire and wheel services, and suspension services. The services are performed by expert mechanics who provide additional perks and amenities.
Via Get News · January 26, 2026
Big Mission Automotive is committed to operating as the premier European auto repair shop serving Colorado Springs, Denver, Castle Rock, Monument, and the entire Front Range. Designed specifically for discerning Audi, BMW, Mercedes-Benz, Mini, Porsche, and Volkswagen owners who have grown tired of impersonal dealership experiences and inflated pricing, Big Mission has emerged as the trusted resource for specialized, relationship-driven automotive care in Colorado.
Via AB Newswire · January 26, 2026
BioMedNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Engages IBN for Corporate Communications Support
Earth Science Tech (OTC: ETST), a strategic holding company advancing a portfolio of operating businesses within regulated healthcare markets, announced that it has engaged InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, to assist with its corporate communications strategy, reflecting the company’s focus on execution, compliance and disciplined scaling across licensed pharmaceutical compounding, digital health and telemedicine platforms, specialty healthcare services and complementary assets, with hands-on operational oversight through wholly owned and majority-owned subsidiaries aimed at building sustainable revenue streams and long-term shareholder value.
Via Investor Brand Network · January 23, 2026
Meta Analysis Finds That Weight Reduction Reduces Severity of Psoriasis
Psoriasis is a chronic skin condition that afflicts at least 60 million individuals globally. Nearly 80% of these affected people also tend to be either overweight or obese. Excess weight has been a known risk factor for psoriasis development, but until now, no rigorous scientific data existed on how the quality of life of patients and the disease severity are impacted when interventions to reduce weight are instituted for psoriatic patients.
Via Investor Brand Network · January 23, 2026
Limo SF VIP has announced the availability of limousine and corporate shuttle car services for business travelers in San Jose.
Via Press Release Distribution Service · January 23, 2026
New Digital Twin Predicts Outcomes of Brain Cancer Treatments
Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a digital twin of a patient’s brain cancer in order to predict how that patient will respond to different treatments. This tool promises to take personalized cancer care a step higher.
Via Investor Brand Network · January 22, 2026
Scientists Develop Next-Gen Antibodies That Boost the Body’s Cancer Killing Cells
Scientists at Southampton University have created new antibodies that supercharge the immune system’s ability to identify and kill cancer cells. This approach involved clustering immune receptors in the body so that stronger signals can be sent out to the specialized cells responsible for zeroing in and killing cancer cells.
Via Investor Brand Network · January 21, 2026
Cars for sale at TM Motors now include a significantly expanded pre-owned vehicle inventory, offering Riverside-area drivers an even wider selection of quality automobiles. Located at 10100 Arlington Ave., the dealership continues building its reputation as a go-to destination for affordable, reliable transportation options. This expansion reflects the company's commitment to meeting growing demand while maintaining the fair pricing and superior service that have defined its approach to automotive retail.
Via AB Newswire · January 20, 2026
BioMedNewsBreaks — Lantern Pharma (NASDAQ: LTRN) Receives FDA Orphan Drug Designation For LP-284 In Soft Tissue Sarcomas
Lantern Pharma (NASDAQ: LTRN) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to LP-284 for the treatment of soft tissue sarcomas, marking the third orphan designation for the program and the sixth overall across the company clinical pipeline. The designation expands LP-284 beyond hematologic malignancies into solid tumors and reflects its synthetic lethal mechanism targeting DNA repair deficiencies, which are common in adult soft tissue sarcomas. Lantern said the designation supports an accelerated regulatory pathway for LP-284 as it continues Phase 1 evaluation in B-cell non-Hodgkin lymphomas and advances development in additional rare cancer indications.
Via Investor Brand Network · January 20, 2026
In today’s competitive manufacturing landscape, an injection mold is more than just a tool—it’s a strategic asset that determines your product’s time-to-market, cost efficiency, and quality consistency. The steel that forms this asset is its very foundation. For Tier-1 automotive suppliers, appliance, furniture, and logistics manufacturers worldwide, navigating complex steel grades and volatile supply chains to make the optimal material choice is a core challenge demanding both technical expertise and commercial insight.
Via AB Newswire · January 19, 2026
Dubai and tourism are two things that go hand in hand since there is an indefinite number of people visiting Dubai every year. And by the look of it, this number is only going to increase in the coming years. The reason there is such a demand to visit Dubai is that there is no […]
Via Worldnewswire · January 18, 2026
Steve’s Imports continues to stand out as a reliable auto repair shop in Portland OR by consistently delivering high-quality workmanship paired with attentive, customer-focused service. Known for servicing a wide range of domestic and import vehicles, the shop has built its reputation by focusing on accuracy, transparency, and long-term vehicle reliability. From everyday maintenance to complex diagnostic challenges, every service is approached with the same goal: ensuring customers feel confident in both the work performed and the people performing it.
Via AB Newswire · January 16, 2026
Experts are Astounded by the Vaccine Policy Change in the US
The recent vaccine policy changes that the U.S. government announced have astounded experts because the changes reduce recommended vaccines by one third and put the U.S. behinds its peer countries. This change shifts the U.S. from the position of leader on vaccination to a country that lags other developed nations on matters of disease prevention.
Via Investor Brand Network · January 16, 2026
Michigan State University Research Says Suppressing Postoperative Pain Could Delay Healing
The normal practice after someone has undergone a surgical procedure has been to administer anti-inflammatory medications. However, new research conducted at Michigan State University (MSU) suggests that this could be counterproductive and may be the reason why some patients develop chronic pain that lasts for years after their surgery.
Via Investor Brand Network · January 15, 2026
Soligenix Inc. (NASDAQ: SNGX) Advances Solutions for Hard-to-Diagnose CTCL
Cutaneous T-cell lymphoma, or CTCL, is a rare form of non-Hodgkin lymphoma that primarily affects the skin, often presenting with symptoms that closely resemble common dermatologic conditions such as eczema or psoriasis, leading to frequent misdiagnosis and delayed treatment. These diagnostic delays can allow the disease to progress silently for years, increasing patient suffering and complicating care. A late-stage biopharmaceutical company, Soligenix (NASDAQ: SNGX) is developing therapies aimed at addressing critical gaps in rare disease treatment, including CTCL.
Via Investor Brand Network · January 14, 2026
BioMedNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Present at Sequire Investor Summit 2026
Oragenics (NYSE American: OGEN) announced that it will present at the upcoming Sequire Investor Summit 2026, scheduled for Jan. 20–22, 2026, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico. During the conference, the Company plans to highlight its novel approach to addressing the significant unmet medical need in concussion and mild traumatic brain injury, including progress toward advancing its ONP-002 clinical program into Phase 2a studies, an area where no approved drug therapies currently exist, according to Oragenics Chief Executive Officer Janet Huffman.
Via Investor Brand Network · January 14, 2026
Oklahoma City, OK - Expert Auto Care continues to provide trusted automotive repair and maintenance services to drivers across Oklahoma City. The auto repair shop serves both domestic and European vehicles, offering solutions that prioritize long-term reliability, safety, and performance. By combining technical expertise with practical service planning, Expert Auto Care helps customers keep their vehicles in optimal condition year-round.
Via GetFeatured · January 13, 2026
Penn State to Participate in Researching Potential Treatment for Pediatric Brain Cancer
A new collaboration between Penn State College of Medicine and Targepeutics seeks to advance research into a promising combination therapy that offers hope to families with children diagnosed with DIPG (diffuse intrinsic pontine glioma).
Via Investor Brand Network · January 13, 2026
Colibri Car Wrap and Detailing regularly works on vehicles driven in Toronto. The shop handles everything from basic wash and wax services to full paint correction, ceramic coating application, and interior restoration for high-end vehicles that need more than a quick run through an automated car wash. Detailing at this level means multi-step paint decontamination, clay bar treatment to remove bonded contaminants, machine polishing to eliminate swirl marks and light scratches, and protective coatings that actually last instead of washing off after three weeks.
Via Get News · January 12, 2026
New ‘Nanozigzag’ Biomaterial Shows Potential in Revolutionizing Cancer Immunotherapy
Immunotherapy has emerged as a more gentle way to treat cancer over the past few years. However, it is very expensive and results are usually inconsistent among patients, especially those suffering from solid tumors. Researchers in Hong Kong have come up with a biomaterial containing silica that can help to address the current shortcomings of immunotherapy and dramatically improve efficacy rates.
Via Investor Brand Network · January 9, 2026
Analysis Finds 40 Million Individuals Seek Health Care Advice from ChatGPT
At least 40 million individuals from around the world use ChatGPT each day seeking information on health care-related topics, an analysis conducted by AI tool Knit. The report underscores how people use the technology and the need for oversight so that millions don’t get wrong information on such an important matter as their health.
Via Investor Brand Network · January 8, 2026
BioMedNewsBreaks – Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) Closes $8.0 Million Registered Direct Offering
Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase up to 7,594,935 additional shares, with net proceeds expected to be used for general corporate purposes and working capital as the company advances its CD19 and CD22-targeted ARTEMIS T-cell therapy programs, including lead candidate EB103. Aegis Capital Corp. acted as exclusive placement agent for the offerings.
Via Investor Brand Network · January 7, 2026
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO to Co-Lead Biopharma Manufacturing Roundtable During HealthIL Week 2026
Scinai Immunotherapeutics (NASDAQ: SCNI) announced that Chief Executive Officer Amir Reichman will co-lead a Manufacturers Association of Israel–organized roundtable discussion titled “Biopharma Manufacturing in Israel: Capabilities, Gaps, and Scale” during HealthIL Week 2026. The session, scheduled for Jan. 19, 2026, at Expo Tel Aviv, will focus on Israel’s biopharma development and manufacturing ecosystem, including early-stage development, CMC activities, and clinical manufacturing, as well as readiness for later-stage and commercial manufacturing. The roundtable is expected to bring together representatives from government agencies, biopharma manufacturers, CDMOs, multinational pharmaceutical companies, biotech firms, and investors to examine current capabilities, structural gaps, and collaboration models shaping the sector’s future.
Via Investor Brand Network · January 7, 2026
